We could see that prostate cancer and ADT are strongly associated with bone metabolism modifications and, in these studies, advanced age, lower body mass index, and elevated prostate specific antigen levels correlated significantly with decreased BMD. This evidence concerns the gene KLK3 and prostate carcinoma.